Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 7.1B | 2.0B | 3.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 544M | 494M | 492M | 532M |
Other operating expenses | 18M | -16M | 13M | 39M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 148M | 145M | 133M | 138M |
Other income expense | 81M | 81M | 172M | 77M |
Pretax income | -862M | 2.9B | -1.6B | 456M |
Tax provision | -205M | 703M | -407M | 115M |
Net income | -657M | 2.2B | -1.2B | 341M |
Basic EPS | -1.2 | 3.9 | -2.0 | 0.6 |
Diluted EPS | -1.2 | 3.8 | -2.0 | 0.6 |
Basic average shares | 558M | 561.5M | 587.1M | 611.6M |
Diluted average shares | 558M | 571M | 587.1M | 612.6M |
EBITDA | — | — | — | — |
Net income from continuing op. | -657M | 2.2B | -1.2B | 341M |
Minority interests | -7M | -51M | 3M | 24M |
Preferred stock dividends | — | — | — | — |